Literature DB >> 34601061

Co-occurrence of preconception maternal childhood adversity and opioid use during pregnancy: Implications for offspring brain development.

Madeleine C Allen1, Nora K Moog2, Claudia Buss3, Elizabeth Yen4, Hanna C Gustafsson1, Elinor L Sullivan5, Alice M Graham6.   

Abstract

Understanding of the effects of in utero opioid exposure on neurodevelopment is a priority given the recent dramatic increase in opioid use among pregnant individuals. However, opioid abuse does not occur in isolation-pregnant individuals abusing opioids often have a significant history of adverse experiences in childhood, among other co-occurring factors. Understanding the specific pathways in which these frequently co-occurring factors may interact and cumulatively influence offspring brain development in utero represents a priority for future research in this area. We highlight maternal history of childhood adversity (CA) as one such co-occurring factor that is more prevalent among individuals using opioids during pregnancy and which is increasingly shown to affect offspring neurodevelopment through mechanisms beginning in utero. Despite the high incidence of CA history in pregnant individuals using opioids, we understand very little about the effects of comorbid prenatal opioid exposure and maternal CA history on fetal brain development. Here, we first provide an overview of current knowledge regarding effects of opioid exposure and maternal CA on offspring neurodevelopment that may occur during gestation. We then outline potential mechanistic pathways through which these factors might have interactive and cumulative influences on offspring neurodevelopment as a foundation for future research in this area.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Brain development; In utero exposure; Maternal childhood adversity; Maternal-placental fetal biology; Opioid epidemic; Prenatal opioid exposure

Mesh:

Substances:

Year:  2021        PMID: 34601061      PMCID: PMC8578395          DOI: 10.1016/j.ntt.2021.107033

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   4.071


  296 in total

1.  Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).

Authors:  Laura M Hodges; Svetlana M Markova; Leslie W Chinn; Jason M Gow; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-03       Impact factor: 2.089

2.  Corticotropin-releasing hormone during pregnancy is associated with infant temperament.

Authors:  Elysia Poggi Davis; Laura M Glynn; Christine Dunkel Schetter; Calvin Hobel; Aleksandra Chicz-Demet; Curt A Sandman
Journal:  Dev Neurosci       Date:  2005       Impact factor: 2.984

3.  Prenatal methadone exposure and child developmental outcomes in 2-year-old children.

Authors:  Terri A Levine; Alison Davie-Gray; Hyun Min Kim; Samantha J Lee; Lianne J Woodward
Journal:  Dev Med Child Neurol       Date:  2021-01-18       Impact factor: 5.449

4.  Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers.

Authors:  Poppy McLaughlin; Helen Mactier; Cheryl Gillis; Tamas Hickish; Anton Parker; Wei-Jun Liang; M David Osselton
Journal:  J Pediatr       Date:  2017-09-01       Impact factor: 4.406

5.  Childhood maltreatment is associated with changes in mitochondrial bioenergetics in maternal, but not in neonatal immune cells.

Authors:  Anja M Gumpp; Christina Boeck; Alexander Behnke; Alexandra M Bach; Laura Ramo-Fernández; Thilo Welz; Harald Gündel; Iris-Tatjana Kolassa; Alexander Karabatsiakis
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-01       Impact factor: 11.205

6.  Women's experience of abuse in childhood and their children's smoking and overweight.

Authors:  Andrea L Roberts; Sandro Galea; S Bryn Austin; Heather L Corliss; Michelle A Williams; Karestan C Koenen
Journal:  Am J Prev Med       Date:  2014-03       Impact factor: 5.043

Review 7.  Reduced hypothalamo-pituitary-adrenal axis stress responses in late pregnancy: central opioid inhibition and noradrenergic mechanisms.

Authors:  John A Russell; Alison J Douglas; Paula J Brunton
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Do maternal opioids reduce neonatal regional brain volumes? A pilot study.

Authors:  Q Yuan; M Rubic; J Seah; C Rae; I M R Wright; K Kaltenbach; J M Feller; M E Abdel-Latif; C Chu; J L Oei
Journal:  J Perinatol       Date:  2014-06-19       Impact factor: 2.521

9.  Epigenetic inheritance of telomere length in wild birds.

Authors:  Christina Bauch; Jelle J Boonekamp; Peter Korsten; Ellis Mulder; Simon Verhulst
Journal:  PLoS Genet       Date:  2019-02-14       Impact factor: 5.917

10.  Physiological markers of anxiety are increased in children of abused mothers.

Authors:  Tanja Jovanovic; Ami Smith; Asante Kamkwalala; James Poole; Tara Samples; Seth D Norrholm; Kerry J Ressler; Bekh Bradley
Journal:  J Child Psychol Psychiatry       Date:  2011-04-19       Impact factor: 8.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.